WorldHealth

BioNTech expects baby Covid-19 trial results by September

BioNTech expects by September the trial results of the Covid-19 vaccine it developed with Pfizer for babies as young as six months old, according to German magazine Spiegel.

A trial published at the end of March found the companies’ Covid-19 vaccine was safe, effective and produces robust antibody responses in adolescents.

The Pfizer/BioNTech two-shot vaccine is already authorised for use in those aged 16 and above.

Comments

Source
Khaleej Times

Related Articles

Back to top button